posted
XKEm Alert ------- ************* names the following stocks to its Stock Pick List: Xechem International Inc. (OTC BB: XKEM), Broadcom Corporation (NASDAQ: BRCM), ADC Telecommunications (NASDAQ: ADCT): Stock Focus List, up 1% on 4 million shares), SINA Corporation (NASDAQ: SINA).
Xechem International Inc. (OTC BB: XKEM) just announced significant progress in its development efforts for NICOSAN™/ HEMOXIN™, a natural product extract which shows promise in the treatment of Sickle Cell Disease (SCD). Xechem has an exclusive world-wide license for the development and sale of NICOSAN™/ HEMOXIN™ from the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, government of Nigeria, which holds the patent.
Other stocks highlighted include Broadcom Corporation (NASDAQ: BRCM): Stock Watch List, down 3% on 9 million shares, SINA Corporation (NASDAQ: SINA): Stock Watch List, down 2% on 2 million shares, ADC Telecommunications (NASDAQ: ADCT): Stock Focus List, up 1% on 4 million shares): Stock Watch List, up 1% on 4 million shares.
“Stocks have been hard-pressed to pick a direction in trading lately, going on a tear for a few days, only to see those gains wane in the next several sessions. The Dow Jones Industrial Average is, in fact, hovering very close to the level it was at when the Federal Reserve began raising rates months ago.” More is available at: http://www.*************/sub_comm.asp.
*************’s Daily Stock Updates:
*************, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a “long term” view of any of the companies listed. For more go to http://www.*************/sub_comm.asp.
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
posted
XKEM HERE!!> XKEM 500mill Revs Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!. Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin. They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 450-500 Mill O/S. They Just One A 4mill Settlement Against Bristol Myers Squib Also. This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem. From Nigerian News Paper.>
Last Updated: 17th March
March 3rd, 2006 Obasanjo to launch locally produced sickle cell drug E-MAIL THIS PRINT THIS
President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder. PATIENCE OGBE Abuja
The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN
The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.
Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.
Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.
Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.
Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.
On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.
"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.
It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."
To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.
The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.
He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.
He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.
He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.
"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."
More In Headlines » Capitalisation in the insurance... » Banks to merge for external... » Multi-purpose halls back in... » Obi to be sworn in today » Delta, militants in stalemate... » pic031706
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
Sounds like they are ready to start production of Nicosan.June looks like the starting date IMO They are in the advanced stages of completing of this 8.5 million dollar facility.Pictures look like it's ready to go!
I've just been convinced that this is gonna roll in June.This website is just up & running I believe.We should be able to get updates from this website on Xechems progress? STRONG BUY MONDAY!!!!!!
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
posted
From : Xechem Pharmaceutical Nig. Ltd. Sent : Tuesday, March 21, 2006 3:16 PM To : Subject : Re: Information
March 21, 2006.
Dear
Thank you for your e-mail of March 21, 2006.
Dr. Ramesh C. Pandey is presently attending Africa Anti Malaria Meeting in Nairobi, Kenya. He is trying to work out plans on projects like Malaria and HIV, etc. It will be premature to make any pronouncements at this moment.
Thank you and best regards.
Sincere,
Col. Bhuwan C. Pandey
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
posted
XKEM.ob ...............Great oportunity to BUY Under 0.0150 cents . HOLD HOLD HOLD this GEM ! amazing oportunity to WIN 500%.
XKEM 500mill Revs
Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!.
Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin.
They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 700 Mill O/S. 30% of this his Owner ALEMBIC Big Indian Biotech.
They Just One A 4mill Settlement Against Bristol Myers Squib Also.
This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem.
From Nigerian News Paper.>
Last Updated: 17th March
March 3rd, 2006 Obasanjo to launch locally produced sickle cell drug E-MAIL THIS PRINT THIS
President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder. PATIENCE OGBE Abuja
The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN
The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.
Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.
Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.
Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.
Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.
On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.
"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.
It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."
To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.
The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.
He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.
He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.
He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.
"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."
More In Headlines » Capitalisation in the insurance... » Banks to merge for external... » Multi-purpose halls back in... » Obi to be sworn in today » Delta, militants in stalemate... » pic031706
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
posted
XKEM.ob ------ late 10K --- Few Days NEWS OUT !!! read Investors incredible oportunity to WIN !!!!! Dr Pandey : We have significantly expanded our operations in Nigeria over the past year. This factor has resulted in our requiring additional time and coordination in completing our disclosure. As a result of the foregoing reasons, we will not, without unreasonable effort and expense, be able to complete our Form 10-KSB within the prescribed time period. The completed filing is expected to be available within the requested fifteen day extension period. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Ramesh Pandey 732-247-3300 ---------------------------------
XKEM.ob ...............Great oportunity to BUY Under 0.0150 cents .HOLD HOLD HOLD this GEM ! amazing oportunity to WIN 500%.
XKEM 500mill Revs Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!. Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin. They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 700 Mill O/S. 30% of this his Owner ALEMBIC Big Indian Biotech. They Just One A 4mill Settlement Against Bristol Myers Squib Also.
This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem. From Nigerian News Paper.>
Last Updated: 17th March
March 3rd, 2006 Obasanjo to launch locally produced sickle cell drug E-MAIL THIS PRINT THIS
President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder. PATIENCE OGBE Abuja
The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN
The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.
Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.
Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.
Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.
Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.
On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.
"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.
It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."
To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.
The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.
He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.
He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.
He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.
"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."
More In Headlines » Capitalisation in the insurance... » Banks to merge for external... » Multi-purpose halls back in... » Obi to be sworn in today » Delta, militants in stalemate... » pic031706
--------------------------------- YAHOO! GROUPS LINKS
Visit your group "ENE-LONG" on the web.
To unsubscribe from this group, send an email to: ENE-LONG-unsubscribe*yahoogroups.com
Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.
-------------------- "Many of life's failures are people who did not realize how close they were to success when they gave up." -
posted
It's been quiet lately. Calm before the storm? I'm holding 790K * .018 avg. and can't decide if I should average down some more. I picked up quite a bit * .016 thinking that was the bottom, but I was wrong. Whats the boards feelings?
posted
I'm averaged to 100k at .0158, thinking about averaging down, so if you have the cash, I'd do it.
If it makes you feel any better, I picked up a bunch of my shares at .02 thinking it was a short pull-back. I was lucky enough to buy some at .01 before the burst (2/3's of which I sold for .028).
Hold on, I'm pretty sure this stock will see .03-.05 by late spring.
IP: Logged |
imakmony2005
unregistered
posted
I keep adding more, This will go up big,imo
IP: Logged |
That is the article in which Turner Isoun is quoted as saying that President Obasanjo will commission the Xechem factory and launch NIPRISAN (NICOSAN TM) "by June." Questions have arisen as to the authenticiy of those quotes by Mr. Isoun.
was written by Peter Egwuatu, a reputable journalist who writes about business matters in Nigeria.
Mr. Egwuatu quotes not only Mr. Isoun (who recommends that Nigerians invest in Xechem), but also President Obasanjo (who praises Xechem and NICOSAN).
Reading these articles together, I believe that it is clearly a question of "when," not "whether," NICOSAN will be registered by NAFDAC and launched at the SHESTCO facility.
I have never before owned a stock that was so openly recommended as an investment by the national government. Folks, registration by NAFDAC is a done deal.
posted
Apr 04, 2006 (M2 PRESSWIRE via COMTEX) -- www.**********, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists: Tower Automotive, Inc. (TWRAQ), Xechem International, Inc. (XKEM), Ceragenix Pharmaceuticals, Inc. (CGXP), Chelsea Therapeutics International, Ltd. (CHTP), IceWEB, Inc. (IWEB), Lexington Resources, Inc. (LXRS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.**********.
IP: Logged |
posted
The company has operations in the United States, India, China, and Nigeria. Xechem International was founded in 1994 by Ramesh C. Pandey and is headquartered in New Brunswick, New Jersey. With 259.69 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of XKEM.
IP: Logged |
posted
XKEm.ob --www.xechemnigeria.org ----- Start Today ------------- OFICIAL NEWS OUT SOON -------- High Recommend Investment ---- Buy Confirmed ------- Easy 0.10 cents ------ Read this registration by NAFDAC is a done deal.
We began to put XKEm.ob on
HIGH RECOMENDATION ....!!!!!!!
after publication of the March 3, 2006 article by Patience Ogbe in the BusinessDay ----
That is the article in which Turner Isoun is quoted as saying that President Obasanjo will commission the Xechem factory and launch NIPRISAN (NICOSAN TM) "by June." Questions have arisen as to the authenticiy of those quotes by Mr. Isoun.
was written by Peter Egwuatu, a reputable journalist who writes about business matters in Nigeria.
Mr. Egwuatu quotes not only Mr. Isoun (who recommends that Nigerians invest in Xechem), but also President Obasanjo (who praises Xechem and NICOSAN).
Reading these articles together, I believe that it is clearly a question of "when," not "whether," NICOSAN will be registered by NAFDAC and launched at the SHESTCO facility.
I have never before owned a stock that was so openly recommended as an investment by the national government. Folks, registration by NAFDAC is a done deal.
quote:Originally posted by Cerebro: XKEM.ob ------ late 10K --- Few Days NEWS OUT !!! read Investors incredible oportunity to WIN !!!!! Dr Pandey : We have significantly expanded our operations in Nigeria over the past year. This factor has resulted in our requiring additional time and coordination in completing our disclosure. As a result of the foregoing reasons, we will not, without unreasonable effort and expense, be able to complete our Form 10-KSB within the prescribed time period. The completed filing is expected to be available within the requested fifteen day extension period. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Ramesh Pandey 732-247-3300
posted
Stock and this board have been pretty quiet. Hopefully when the 10-ksb is released, they'll have some updates to report. Holding 675K shares and waiting for news.
posted
ok, fellow board members. whats the take on the 10-ksb? I haven't decided if I'm going to buy more on this latest drop. I'll probably sit on the sidelines today and just watch the action.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
